Clinical Trial

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Name: C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV — clinical trial record (NCT07037277)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-30

notable Trial sites expanded: 89 -> 106 locations 2026-04-14

Trial Details

NCT Number	NCT07037277
Lead Sponsor	Atea Pharmaceuticals, Inc.
Conditions	HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
Enrollment	880 participants
Start Date	2025-06-02
Primary Completion	2026-12 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-29